Latest News and Press Releases

CARY, N.C., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Chiesi USA (key-A-zee), the U.S. affiliate of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), has...

- Program grants access to investigational therapy for Fabry disease patients in the United States who cannot be adequately treated with currently available FDA-approved drugs - BOSTON, Dec. 23,...

Jon Zwinski succeeds Ken McBean as company advances global therapeutic efforts CARY, N.C., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Chiesi USA (key-ay-zee), the U.S. affiliate of Chiesi Farmaceutici...

CARY, N.C., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Chiesi USA (key-ay-zee), a specialty pharmaceutical company based in Cary, N.C., is proud to once again support March of Dimes in its mission to improve...

CARY, N.C., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Chiesi USA (key-ay-zee), a specialty pharmaceutical company based in Cary, N.C., earned the Triangle Business Journal’s 2020 Corporate Philanthropy...

CARY, N.C., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Chiesi USA, Inc., the U.S. affiliate of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), received U.S....

Disease education program aims to help patients, caregivers and families affected by Fabry disease to make informed healthcare decisions Program includes new resources for healthcare professionals to...

BOSTON and CARMIEL, Israel, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare group (Chiesi...

CARY, N.C., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Chiesi USA (key-ay-zee), a specialty pharmaceutical company based in Cary, North Carolina, was named Company of the Year by the Triangle Business...

Chiesi Group reports €1,992.81 million in revenue, around 6,000 employees, an 11% reduction in CO2 emissions and more than a fourfold increase in renewable energy consumption.The report, which is...